Showing results (61-70 of 661) with videos related to
Sort By:
Pageof 67
Endocrine-Related Cancer|March 4, 2008
Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumorsAmy Moreno, Argun Akcakanat, Mark F Munsell, et al.Scientific Reports|July 29, 2022
CombPDX: a unified statistical framework for evaluating drug synergism in patient-derived xenograftsLicai Huang, Jing Wang, Bingliang Fang, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 8, 2025
Bispecific Antibodies in Hematologic and Solid Tumors: Current Landscape and Therapeutic AdvancesLorenzo Guidi, Julian Etessami, Carmine Valenza, et al.Cancer Science|March 31, 2011
Nanomedicine in cancer therapy: innovative trends and prospectsElvin Blanco, Angela Hsiao, Aman P Mann, et al.The Lancet. Oncology|February 23, 2010
Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient careDebashish Bose, Funda Meric-Bernstam, Wayne Hofstetter, et al.Molecular Oncology|November 11, 2011
Molecular-targeted nanotherapies in cancer: enabling treatment specificityElvin Blanco, Angela Hsiao, Guillermo U Ruiz-Esparza, et al.Nature Reviews. Clinical Oncology|October 16, 2023
Molecular tumour boards - current and future considerations for precision oncologyApostolia M Tsimberidou, Michael Kahle, Henry Hiep Vo, et al.BMC Genomics|July 1, 2016
Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer typesTenghui Chen, Zixing Wang, Wanding Zhou, et al.Cancer|February 13, 2008
Commonly cited website quality criteria are not effective at identifying inaccurate online information about breast cancerElmer V Bernstam, Muhammad F Walji, Smitha Sagaram, et al.Med (New York, N.Y.)|March 9, 2023
The abscopal effect in patients with cancer receiving immunotherapyBlessie Elizabeth Nelson, Jacob J Adashek, Steven H Lin, et al.Pageof 67